Biochemical markers of myocardial injury

The serum markers of myocardial injury are used to help in establishing the diagnosis of myocardial infarction. The older markers like aspartate amino-transferase, creatine kinase, lactate dehydrogenase etc. lost their utility due to lack of specificity and limited sensitivities. Among the currently available markers cardiac troponins are the most widely used due to their improved sensitivity specificity, efficiency and low turn around time. Studies have shown that cardiac troponins should replace CKMB as the diagnostic ‘gold standard’ for the diagnosis of myocardial injury. The combination of myoglobin with cardiac troponins has further improved the accuracy in the diagnosis of acute coronary syndromes and thereby reducing the hospital stay and patients' money. Among the other new markers of early detection of myocardial damage, heart fatty acid binding protein, glycogen phosphorylase BB and myoglobin/carbonic anhydrase III ratio seem to be the most promising. But the search for the most ideal marker of myocardial injury is still on.

[1]  T. Takala,et al.  Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. , 1990, Clinical chemistry.

[2]  K. Dickstein,et al.  Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin T. , 1996, Scandinavian journal of clinical and laboratory investigation.

[3]  M. Péoc'h,et al.  Systemic granulomatous reaction to a foreign body after hip replacement. , 1996, The New England journal of medicine.

[4]  F. Dati,et al.  Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage , 1999, Clinical chemistry and laboratory medicine.

[5]  A. Wu.  Creatine kinase isoforms in ischemic heart disease. , 1989, Clinical chemistry.

[6]  G. Perkoff.  Alcoholic myopathy. , 1971, Annual review of medicine.

[7]  J. Walton,et al.  Serum-creatine-kinase in cases of stroke, head injury, and meningitis. , 1967, Lancet.

[8]  Lafair Js,et al.  Alcoholic myopathy. With special reference to the significance of creatine phosphokinase. , 1968 .

[9]  D. Morrow,et al.  Troponins in Acute Coronary Syndromes , 2003, Seminars in vascular medicine.

[10]  R H Christenson,et al.  Biochemical markers of the acute coronary syndromes. , 1998, Clinical chemistry.

[11]  Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. , 1979, Circulation.

[12]  D. Baron.  Aspects of Hypophysectomy * , 1956, Journal of clinical pathology.

[13]  A. Remppis,et al.  Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. , 1991, The American journal of cardiology.

[14]  F. Apple,et al.  Cardiac troponin T composition in normal and regenerating human skeletal muscle. , 1997, Clinical chemistry.

[15]  H. Sacks,et al.  An evaluation of serum transaminase in the jaundice states. , 1960, American journal of clinical pathology.

[16]  J. Glatz,et al.  Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man , 1992, Molecular and Cellular Biochemistry.

[17]  T. Kuwana,et al.  Early Diagnosis of Acute Myocardial Infarction by CK-MB Mass Measurements , 1992, Annals of clinical biochemistry.

[18]  E. Zsigmond,et al.  Elevated Serum‐Creatine Phosphokinase Activity in a Family With Malignant Hyperpyrexia , 1972, Anesthesia and analgesia.

[19]  D. Waters,et al.  Prognostic value of cardiac troponin I in patients with chest pain. , 1996, Clinical chemistry.

[20]  D. Waters,et al.  Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. , 1998, The American journal of cardiology.

[21]  K. Punnonen,et al.  Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. , 2002, Clinical biochemistry.

[22]  R Roberts,et al.  Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. , 1990, Circulation.

[23]  K. Kawamura,et al.  Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB , 2000, Clinical chemistry and laboratory medicine.

[24]  L. Goldman,et al.  Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. , 1986, Annals of internal medicine.

[25]  J. German,et al.  MONGOLISM BY TERTIARY TRISOMY , 1975, The Lancet.

[26]  M. Waterman,et al.  Detection of myoglobin by radioimmunoassay in human sera: Its usefulness and limitations as an emergency room screening test for acute myocardial infarction☆ , 1978 .

[27]  K. Thygesen,et al.  Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5-year follow-up study in 156 consecutive patients. , 1992, Cardiology.

[28]  T. Henry,et al.  Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. , 1996, American journal of clinical pathology.

[29]  R H Christenson,et al.  Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[30]  H. Naruse,et al.  Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. , 1997, Clinical chemistry.

[31]  M. Panteghini,et al.  Diagnostic application of CK-MB mass determination. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[32]  N. Tietz.  Fundamentals of Clinical Chemistry , 1970 .

[33]  J. Zimmerman,et al.  Diagnostic marker cooperative study for the diagnosis of myocardial infarction. , 1999, Circulation.

[34]  M. McQueen,et al.  Assessment of the accuracy of serial electrocardiograms in the diagnosis of myocardial infarction. , 1983, American heart journal.

[35]  S. Armstrong.  Protein kinase activation and myocardial ischemia/reperfusion injury. , 2004, Cardiovascular research.

[36]  A. Wu.  Analytical and clinical evaluation of new diagnostic tests for myocardial damage. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[37]  J. H. Wilkinson,et al.  The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxoedema. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[38]  A. Usui,et al.  S-100ao protein in serum during acute myocardial infarction. , 1990, Clinical chemistry.

[39]  M. Pincus,et al.  Use of creatine kinase MB isoenzyme for diagnosing myocardial infarction when total creatine kinase activity is high. , 1988, Clinical chemistry.

[40]  F. Harrell,et al.  Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .

[41]  A. Go,et al.  The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. , 2001, Journal of the American College of Cardiology.

[42]  S. Ebashi,et al.  HIGH CREATINE PHOSPHOKINASE ACTIVITY OF SERA OF PROGRESSIVE MUSCULAR DYSTROPHY , 1959 .

[43]  W. Rottbauer,et al.  Troponin T: a diagnostic marker for myocardial infarction and minor cardiac cell damage. , 1996, European heart journal.

[44]  R. Renneberg,et al.  A superior early myocardial infarction marker , 2004, Zeitschrift für Kardiologie.

[45]  Young Gp.  Myoglobin and creatine kinase-MB. , 1996 .

[46]  Time Changes of Creatine Kinase and Creatine Kinase-MB Isoenzyme versus Discrimination Values in the Diagnosis of Acute Myocardial Infarction: What is the Optimal Method for Displaying the Data? , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[47]  G. Wagner,et al.  Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve. , 1991, American heart journal.

[48]  A. Jaffe,et al.  Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. , 1994, Clinical chemistry.

[49]  J H Keffer,et al.  Myocardial markers of injury. Evolution and insights. , 1996, American journal of clinical pathology.

[50]  N. Kaneko,et al.  Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[51]  T. Takano,et al.  Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[52]  T. Nageh,et al.  Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. , 2003, International journal of cardiology.

[53]  M. Niemelä,et al.  Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction. , 2003, International journal of cardiology.

[54]  F. Vassella,et al.  THE DIAGNOSTIC VALUE OF SERUM CREATINE KINASE IN NEUROMUSCULAR AND MUSCULAR DISEASE. , 1965, Pediatrics.

[55]  J. Mair,et al.  Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. , 1995, Clinical chemistry.

[56]  Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. , 1994, The New England journal of medicine.

[57]  A. Jaffe,et al.  Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. , 1997, Circulation.

[58]  P. Mair,et al.  Glycogen Phosphorylase Isoenzyme BB Mass Release After Coronary Artery Bypass Grafting , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[59]  H. Thode,et al.  Improved specificity of myoglobin plus carbonic anhydrase assay versus that of creatine kinase-MB for early diagnosis of acute myocardial infarction. , 1996, Annals of emergency medicine.

[60]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[61]  R. Nagai,et al.  Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction. , 1987, Circulation.

[62]  C. Heusghem,et al.  Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. , 1986, Clinical chemistry.

[63]  F. Apple,et al.  Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. , 1995, Clinical chemistry.

[64]  J. H. Wilkinson,et al.  SERUM "α-HYDROXYBUTYRIC DEHYDROGENASE" IN MYOCARDIAL INFARCTION AND IN LIVER DISEASE , 1961 .

[65]  J. Ravkilde,et al.  Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. , 1993, Scandinavian journal of clinical and laboratory investigation.

[66]  A. Jaffe,et al.  Nature and time course of generation of creatine kinase, MB fraction in vivo☆ , 1992 .

[67]  M. Panteghini.  Serum isoforms of creatine kinase isoenzymes. , 1988, Clinical biochemistry.

[68]  Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction , 1996 .

[69]  L. Wallentin,et al.  Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. , 2000, The American journal of cardiology.

[70]  P. K. Rosenthal,et al.  Cardiac isoenzyme methodology and the diagnosis of acute myocardial infarction. , 1983, American journal of clinical pathology.

[71]  E. Zsigmond,et al.  Abnormal Creatine‐Phosphokinase lsoenzyme Pattern in Families With Malignant Hyperpyrexia , 1972, Anesthesia and analgesia.

[72]  Sunil V. Rao,et al.  Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. , 2003, The American journal of cardiology.

[73]  R. D. de Winter,et al.  Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. , 1995, Circulation.

[74]  J. Mair.  Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[75]  R. Roberts.  Enzymatic diagnosis of acute myocardial infarction. , 1988, Chest.

[76]  M. Yamaguchi,et al.  Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. , 2004, The Journal of thoracic and cardiovascular surgery.

[77]  M. Kita,et al.  [Usefulness of cardiac troponin I in patients with acute myocardial infarction]. , 2002, Rinsho byori. The Japanese journal of clinical pathology.

[78]  E. Krause,et al.  Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. , 1994, British heart journal.

[79]  C. Agress.  Evaluation of the transaminase test. , 1959, The American journal of cardiology.

[80]  J. Arenas,et al.  Activities of creatine kinase and its isoenzymes in serum in various skeletal muscle disorders. , 1988, Clinical chemistry.

[81]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.